Membrane, intracellular, plasma and urinary sodium and potassium in occupational lead exposure: Effects of vitamin C supplementation

Trace Elements and Electrolytes

Volumn 26, Issue 2, 2009, Pages 49-59

  Okediran, B S ^a   Abam, E ^a   Odukoya, O O ^a   Adamson, I ^a   Ademuyiwa, O ^a  

^a FEDERAL UNIVERSITY OF AGRICULTURE   (Nigeria)

Author keywords

Artisans in Nigeria; Lead poisoning; Na+ K+ ATPase; Sodium potassium homeostasis; Vitamin C

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASCORBIC ACID; LEAD; POTASSIUM; SODIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPONATREMIA; LEAD METABOLISM; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; METAL METABOLISM; NIGERIA; OCCUPATIONAL EXPOSURE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM URINE LEVEL; URINARY EXCRETION; VITAMIN SUPPLEMENTATION;

EID: 70350406532     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/tep26049     Document Type: Article

References (47)

1. Abam E, Okediran BS, Odukoya OO, Adamson I, Ademuyiwa O. Reversal of ionoregulatory disruptions in occupational lead exposure by vitamin C. Environ Toxicol Pharmacol. 2008; doi:10.1016/J.etap.2008.05.2008.
2. Ademuyiwa O, Ugbaja RN, Ojo DA, Owoigbe AO, Adeokun SE. Reversal of aminolevulinic acid dehydratase (ALAD) inhibition and reduction of erythrocyte protoporphyrin levels by vitamin C in occupational lead exposure in Abeokuta, Nigeria. Environ Toxicol Pharmacol. 2005a; 20: 404-411.
3. Ademuyiwa O, Ugbaja RN, Idumebor F, Adebawo O. Plasma lipid profiles and risk of cardiovascular disease in occupational lead exposure in Abeokuta, Nigeria. Lipids Health Dis. 2005b; 4: 19.
4. Ademuyiwa O, Ugbaja RN, Rotimi SO, Abam E, Okediran BS, Dosumu OA, Onunkwor B. Erythrocyte acetylcholinesterase activity as a surrogate indicator of lead-induced neurotoxicity in occupational lead exposure in Abeokuta, Nigeria. Environ Toxicol Pharmacol. 2007; 24: 183-188.
5. Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicol. 1995; 97: 23-38.
6. Banks EG, Ferreti LE, Shucard DW. Effect of low level lead exposure on cognitive function in children: a review of behavioral, neurophysiological and biological evidence. Neurotoxicol. 1997; 18: 237-282.
7. +-ATPase activity in erythrocyte membranes from patients with phenylketonuria. Paediatr. Res. 2001; 50: 56-60.
8. Brines ML, Robbins RJ. Inhibition of a2-a3-sodium pump isoforms potentiate glutamate neurotoxicity. Brain Res. 1992; 591: 94-102.
9. Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10μg per deciliter. N Engl J Med. 2003; 348: 1517-1526.
10. Canfield RL, Gendle MH, Cory-Slechta DA. Impaired neuropsychological functioning in lead-exposed children. Dev. Neuropsychol. 2004; 26: 513-540.
11. 2+-stimulated ATPase activity. Anal Biochem. 1986; 157: 375-380.
12. Chisolm Jr JJ. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposure. Environ Health Perspect. 1990; 89: 67-74.
13. Cory-Slechta DA. Lead-induced impairments in complex cognitive function: offerings from experimental studies. Child Neuropsychol. 2003; 9: 54-75.
14. Dawson EB, Evans DR, Harris WA, Teter MC, McGanity WJ. The effect of ascorbic acid supplementation on the blood levels of smokers. J Am Coll Nutr. 1999; 18: 166-170.
15. De Roos FJ. Smelters and metal reclaimers. In: Greenberg MI, Hamilton RJ, Phillips SD, McCluskey GJ (eds) Occupational, industrial, and environmental toxicology. 2nd ed. Philadelphia: Mosby; 2003. p. 388-397.
16. Donaldson WE, Knowles SO. Is lead toxicosis a reflection of altered fatty acid composition of membranes? Comp Biochem. Physiol. 1993; 104C: 377-379.
17. Dosumu O, Onunkwor B, Odukoya O, Arowolo T, Ademuyiwa O. Biomarkers of lead exposure in automechanics in Abeokuta, Nigeria. Trace Elem Electro. 2005; 22: 185-191.
18. Gick GG, Hatala MA, Chon D, Ismail-Beigi F. Na,K-ATPase in several tissues of the rat: Tissue-specific expression of subunit mRNAs and enzyme activity. J Membr Biol. 1993; 131: 229-236.
19. Gilbert SG, Weiss B. A rationale for lowering the blood lead action level from 10 to 2μg/dl. Neurotoxicol. 2006; 27: 693-701.
20. Goodman DPB, Allen JE, Rasmussen H. Studies on the mechanism of action of aldosterone: hormone-induced changes in lipid metabolism. Biochem. 1971; 10: 3825-3831.
21. Goyer RA. Toxic effects of metals. In: Amdour MO, Doull J, Klaassen CD (Eds.): Cassarett and Doull's Toxicology. The Basis Science of Poisons. 4th ed. New York: Pergamon Press; 1991. p. 623-680.
22. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Rad Biol Med. 2000; 29: 927-945.
23. Hanahan DJ, Ekholm JE. The preparation of red cell ghosts (membranes). In: Fleischer S, Packer L (eds) Methods in enzymology. Vol. 31. Biomembranes, Part A. New York: Academic Press; 1974. p. 168-172.
24. Hoffmann JF, Kennedy BG, Lunn G. Modulators of red cell Na/K pump rates. Prog Clin Biol Res. 1981; 56: 5-9.
25. Horisberger J-D. Inhibitors of the sodium pump: Toxins, then drugs, and now hormones. Arch Toxicol. 1995; 17 (Suppl): 116-124.
26. Hsu P-C, Guo YL. Antioxidant nutrients and lead toxicity. Toxicol. 2002; 180: 33-44.
27. Ibim SEM, Trotman J, Musey PI, Semafuko WEB. Depletion of essential elements by calcium disodium EDTA treatment in the dog. Toxicol. 1992; 73: 229-237.
28. Kisters K, Tokmak F, Kosch M, Louwen F, Gremmler B, Ulbricht LJ, Funke C, Wessels F, Hausberg M. The role of increased membrane calcium concentration in primary hypertension and hypertension in pregnancy. Trace Elem Electro. 2002; 19: 197-201.
29. Kosch M, Hausberg M, Westermann G, Koeneke J, Matzkies F, Rahn KH, Kisters K. Alterations in calcium and magnesium content of red cell membranes in patients with primary hypertension. Am J Hypertens. 2001; 14: 254-258.
30. Lees GJ. Contributory mechanisms in the causation of neurodegenerative disorders. Neurosci. 1993; 54: 287-322.
31. Lees GJ, Leong W. The sodium-potassium-ATPase inhibitor ouabain is neurotoxic in the rat substantia nigra and striatum. Neurosci Lett. 1995; 188: 113-116.
32. Lin-Fu JS. Modern history of lead poisoning: a century of discovery and rediscovery. In: Needleman HL (ed) Human lead exposure. CRC Press: Boca Raton. 1991; p. 23-43.
33. Needleman HL, Schell A, Bellinger D, Leviton A, Allred E. The long-term effects of exposure to lead in childhood. An 11-year follow-up report. N Engl J Med. 1990; 322: 83-88.
34. Nehru B, Sidhu P. Behavior and neurotoxic consequences of lead on rat brain followed by recovery. Biol Trace Elem Res. 2001; 84: 113-121.
35. Ogunseitan OA, Smith TR. The cost of environmental lead (Pb) poisoning in Nigeria. Afr J Environ Sci Tech. 2007; 1: 027-036.
36. Onunkwor B, Dosumu O, Odukoya OO, Arowolo T, Ademuyiwa O. Biomarkers of lead exposure in petrol station attendants and auto-mechanics in Abeokuta, Nigeria: effects of 2-week ascorbic acid supplementation. Environ Toxicol Pharmacol. 2004; 17: 169-176.
37. Park SK, Schwartz J, Weisskopf M, Sparrow D, Vokonas PS, Wright RO, Coull B, Nie H, Hu H. Low-level lead exposure, metabolic syndrome, and heart rate variability: the VA normative aging study. Environ. Health Perspect. 2006; 114: 1718-1724.
38. +-ATPase in the brain. Epilepsy 1992; 33: 58-64.
39. Sachs L. Angewandte Statistik. Berlin: Springer-Verlag; 1983.
40. Scheiner-Bobis G. The sodium pump. Its molecular properties and mechanics of ion transport. Eur J Biochem. 2002; 269: 2424-2433.
41. Schmidt U, Schmid J, Schmid H, Dubach UC. Sodium- and potassium-activated ATPase. A possible target of aldosterone. J Clin Invest. 1975; 55: 655-660.
42. Seppalainen AM, Hernberg S, Vesanto R, Kock B. Early neurotoxic effects of occupational lead exposure: a prospective study. Neurotoxicol. 1983; 4: 181-192.
43. Smeltzer SC, Bare BG. Brunner and Suddarth's textbook of medical-surgical nursing. 10th ed. Philadelphia: Lippincott, Williams and Wilkins; 2004.
44. Spivey A. The weight of lead. Effects add up in adults. Environ. Health Perspect. 2007; 115: A31-A36.
45. Staudinger KC, Roth VS. Occupational lead poisoning. Am Fam Phys. 1998; 27: 719-526.
46. Turnheim K. Wasser und Elektrolyte. Therapie von Störungen des Wasser- und Elektrolythaushaltes sowie des Säure-Basen-Gleichgewichts. In: Forth W, Henschler D, Rummel W, Starke K (eds) Allgemeine und spezielle Pharmakologie und Toxikologie. Mannheim: B.I. Wissenschaftsverlag; 1992. p. 410-423.
47. Weissman N, Pileggi VJ. Inorganic ions. In: Henry RJ, Cannon DC, Winkelman JW (eds) Clinical chemistry. Principles and technics. 2nd ed. Hagerstown, Maryland: Harper and Row Publishers; 1974. p. 639-754.